February 21st, 2025
Description
Medical information is constantly being updated and new clinical trials reported. Treatment algorithms and clinical guidelines are modified year-round at specialty conferences and by national committees such as the NCCN guidelines. Thus, conferences such as our GI Oncology Symposium provide a unique opportunity to summarize and educate physicians and allied healthcare providers to ensure they are equipped to provide state of the art care for their patients. It is very challenging for OSU and community oncology physicians and allied healthcare providers to stay up to date in the management of GI oncology patients and to implement these changes in clinical practice to improve patient care.
To ensure comprehensive review of updated oncology care in this symposium, we have included all the main specialties involved in GI oncology cancer care-Surgical oncology, Colorectal surgery, Medical oncology, Radiation oncology, interventional radiology, advanced endoscopy team, clinical nurse specialists, immuno-oncology experts and gastroenterology. Thus, specific knowledge gaps will be addressed, particularly in relation to the unique role the various sub-specialties play in the multidisciplinary care of GI oncology patients. Patient case studies will be discussed in the form of the virtual tumor board at the end of each session allowing application of the new information to tailor individualized care for patients with GI tumors.
For pricing information, see pricing tab below.
Dates and Times
Start: 2/21/2025 8:00 AM
End: 2/21/2025 4:25 PM
Objectives
1. Describe the updated evidence for management of borderline resectable and metastatic pancreatic adenocarcinoma
2. Describe the management of locoregional esophageal adenocarcinoma of the esophagus
3. Describe optimal management of nutrition in patients with esophageal cancer
4. Be aware of the unique survivorship challenges experienced by patients with early onset colorectal cancer
5. Describe the optimal management of metastatic colorectal cancer including systemic therapy and locoregional management of metastases
6. Describe the management of toxicities associated with immunotherapies
7. Describe the role of the interventional radiologist in the diagnosis and management of biliary tract cancers
Agenda
8:00 AM Welcoming Remarks
8:10 AM
Session 1: Pancreas Cancer
Moderator: Arjun Mittra
8:15 AM
Talk 1: Updates in systemic therapy options for advanced PDAC
8:35 AM
Talk 2: Contemporary management of borderline resectable and locally advanced PDAC
8:55 AM
Talk 3: Role of locoregional therapy for oligometastatic disease in pancreatic cancer
9:15 AM
Talk 4: Endoscopic palliation of advanced pancreaticobiliary cancers
9:35 AM Tumor board
10:05 AM Introduction
Session 2: Esophageal cancer
Moderator: Ning Jin
10:10 AM
Talk 1: Updates in the management of localized esophageal adenocarcinoma
10:30 AM
Talk 2: Management of esophageal squamous cell carcinoma
10:50 AM
Talk 3: Nutritional optimization of patients with advanced upper GI cancers
11:10 AM Tumor board
11:30 AM Lunch & Shared Resources
12:15 PM KEYNOTE: Eileen M. O’Reilly, MD, FASCO
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary & Neuroendocrine Cancers
Chair, Human Research Protection Program & IRB
Co-Director Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research
Attending Physician, Member, Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
1:15 PM
Session 3: Management of advanced colorectal cancer
Moderator: Lisa Cunningham
1:20 PM
Talk 1: Novel targeted and immune based systemic therapies for colorectal cancer
1:40 PM
Talk 2: Management of colorectal liver metastases
2:00 PM
Talk 3: Locoregional therapies for extra-hepatic metastatic disease
2:20 PM
Talk 4: Early Onset Colorectal Cancer – distinct profiles and challenges in survivorship care
2:40 PM Tumor board
3:00 PM
Session 4: Biliary tract cancer
Moderator: Sameek Roychowdhury
3:05 PM
Talk 1: Advances in systemic therapies for biliary tract cancers
3:25 PM
Talk 2: Management of Immunotoxicities of novel immunotherapies
3:45 PM
Talk 3: Role of IR in diagnosis and management of biliary tract cancers
4:05 PM Tumor board
4:25 PM
Alternative Session 4: Supportive Care
4:30 PM
Talk 1: Advanced Care Planning in Oncology Practice
4:55 PM Closing remarks
Pricing
| Tier | Price |
|---|---|
| Non-OSU MD, DO and PhD | $100.00 |
| OSUCCC - James Oncology Faculty/Staff | $0.00 |
| OSU Faculty/Staff non-Oncology | $50.00 |
| Residents/Students/Fellows | $0.00 |
| All other Professionals | $125.00 |
Location
The Grand Event Center
820 Goodale Blvd.
Columbus, OH 43212
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.